Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-03-04
1993-09-28
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514419, 514423, 514561, 514562, 514565, 514824, A61K 31415, A61K 3140, A61K 31195
Patent
active
052486885
ABSTRACT:
A method and substrate composition for treating atherosclerosis are provided. The method involves parenterally administering the substrate composition as an aqueous solution to substantially lower plasma cholesterol and substantially reverse arterial plaque deposition and degenerative changes associated with atherosclerosis. The substrate compositions include mixtures of biologically active levorotatory amino acids as the antiatherosclerotic agent.
REFERENCES:
patent: 2411897 (1947-12-01), Sahyun
patent: 2457820 (1949-01-01), Howe et al.
patent: 2965542 (1960-12-01), Castaigne
patent: 3574857 (1971-04-01), Cevallos
patent: 3764703 (1973-10-01), Bergstrom et al.
patent: 3832465 (1974-08-01), Ghadimi
patent: 3920838 (1975-11-01), Flatt et al.
patent: 3950529 (1976-04-01), Fisher et al.
patent: 4103021 (1978-07-01), Carr
patent: 4167562 (1979-09-01), Evers
patent: 4430338 (1984-02-01), Jansen et al.
patent: 4532129 (1983-07-01), Comi et al.
patent: 4604286 (1986-08-01), Kawajiri
patent: 4812441 (1989-03-01), Kawai et al.
Dudrick, D., et al. J. Parenteral and Enteral Nutr. 9, No. 1 (1985), p. 116.
Sugano, M. et al. Ann. Nutr. Metab., 28 (1984), 192-99.
Redgrave, T. G., et al., Atherosclerosis 52(1984), 349-51.
Sugiyama, K., et al., J. Nutr. Sci. 32(6) 623-33 (1986).
Schwartz, R. G. et al. J. Clin. Invest., 75 (1985), 1204-11.
Yagasaki, K., et al. Nutr. Reports Intnl. 34, No. 1 (Jul. 1986), 59-66.
Kramer, J. H., et al. Am. J. Physiol., 240 (Heart Cir. Phy. 9) (1981) H238-46.
Azuma, J. et al., Tanrine: Biological Achions and Clinical Perspectives, (1985) 195-213.
Kritschevsky, D., et al., Atherosclerosis, 26 (1977) 397-403.
Kritchevsky, D. et al., Atherosclerosis, 39 (1981) 169-75.
Kritchevsky, D. et al. Atherosclerosis, 41 (1982) 429-31.
Dudrick, S. brochure of USV Labs (1982) "Parenteral Nutrition for Hospitalized Patients, Case Studies in Parenteral Nutrition", No. 3, A Severely Burned Patient.
Dudrick, S. et al., Contemp. Ob/Gyn Special Issue, Update on General Surgery (1983) 95-96, 101-03.
Dudrick, S., et al., Heart and Lung, 12 No. 2 (1983) 195-201.
Dudrick et al., Fed. Proc., 43, No. 7 (1984) Abstract 3537.
Dudrick, S. Annals of Surgery, 199, No. 6 (1984) 770-81.
Dudrick, S., Arch. Surg. 120 (1985) 721-27.
Katan, M., et al. Atherosclerosis, 43 (1982), 381-92.
Kritchevsky, D. et al. Soy Protein Prev. Athero. Proc. Int. Symp. 4th (1982) 1-11.
West; C., et al. Atherosclerosis, 47 (1983), 263-70.
Boers, G. et al. J. Clin. Inv. 72 (1983) 1971-76.
Perl, M. et al. Psychosomatics, 22 (No. 12) 1981.
Dudrick, S. et al. 13th International Cancer Congress, Part D, 161-70 (1983).
"Crystalline Amino Acid Solutions-Travasol.RTM." in AMA Drug Evaluations (1980) Chicago, 4th edition.
Kritchevsky, D. Atherosclerosis, 49:209-219 (1983).
Sanchez, A. et al., Nutrition Reports Intn. 28(3) 497-508 (1983).
O'Donnell, J. et al., Southern Med. J. 76, No. 11, 1344-8 (1983).
Dudrick, S. et al. Surgery, 64, No. 11 (1986), 134-42.
Dudrick S. J., Parenteral Nutr. 1, No. 1, 23-29 (1977).
Dudrick, S. J. Parenteral and Enteral Nutri. 3, No. 6 (1979) 444-51.
Dudrick Medical Research Fund I, Ltd.
Henley III Raymond J.
Waddell Frederick E.
LandOfFree
Method and substrate composition for treating atherosclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and substrate composition for treating atherosclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and substrate composition for treating atherosclerosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2191099